ÐÏà¡±á>þÿ :<þÿÿÿ9ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á€ ð¿Lbjbj÷÷ 4$xxLÿÿÿÿÿÿ·((kkkkkÿÿÿÿ$£È$<¿¿¿¿¿®®®k$m$m$m$m$m$m$'¢¦)Rm$k®®®®®m$kk¿¿ï‚$¤¤¤®"k¿k¿k$¤®k$¤¤Žß!ø«#¿ÿÿÿÿ`°q$T|ÍÐ"×"W$˜$0È$ç"Äø)ò²ø) «#«#ø)k¿#˜®®¤®®®®®m$m$¤®®®È$®®®®ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿø)®®®®®®®®®( 1: DRUG DISCOVERY AND DEVELOPMENT (MSc/PgDip/PgCert) 57B220B1/61B220VX/62B220VZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard in Pharmacology, Pharmacy or a relevant Science subject (e.g. Biochemistry, Biomedical Sciences, Biology). Duration: 12 months full-time or 24 months part-time (MSc); 9 months full-time or 18 months part-time (PgDip). Aim: To equip students for careers developing and expanding current knowledge of drug discovery and development. To achieve this the programme will provide a multi-disciplinary approach to the study of drug discovery and development; mechanisms of drug action; preclinical and clinical trials; and regulatory affairs. Content: The programme of taught courses will comprise lectures, tutorials, practical classes and demonstrations. The curriculum includes biochemical and molecular aspects of drug action; drug transport, metabolism and excretion; toxicology; pharmacokinetics; statistics; computing studies; industrial aspects of drug development; therapeutic drug monitoring; the influence of disease on drug handling; drug-drug interactions; the design and conduct of volunteer and clinical trials; monitoring drug safety. Candidates shall be required to attend the following designated programme of courses: Stage 1 MT5003 Drug Metabolism and toxicology (15 credits) BT5010 Small Molecule drug discovery (25 credits) BT5011 Introduction to Bio-Business and the commercialisation of bioscience Research (10 credits) GS50M1 Generic Skills (0 credits) SK5003 Information Skills (0 credits) And one of the following electives MB5015 Molecular biology basics and cloning labs (15 credits) PU5002 Health Economics (10 credits) MT50xx Molecular pharmacology (15 credits) PU5005 Statistics (10 credits) Stage 2 BT5508 Advanced Bio-Business and the commercialisation of bioscience research (15 credits) BT5502 Biologic therapies (25 credits) MT5503 Pharmacokinetics (10 credits) MT5515 Basic Research methods (15 credits) The following electives are also available MT5501 Pharmacovigilance (5 credits) BT5901 Laboratory techniques core skills (10 credits) Recommended for those taking a lab based project MT55EP Career and Employability for Postgraduates (5 credits) Stage 3 MT5903 Research Project (60 credits) Diploma candidates may be allowed to transfer to the MSc if they complete the above programme at an appropriate standard. No candidate will be allowed to progress to Stage 3 as an MSc candidate if they fail to achieve an appropriate standard in the taught part of the programme. MSc candidates with a registered medical qualification may be able to carry out a clinical research project in the final stage under supervision of one of the medical staff. Assessment: By practical work, by written essays, written examinations and by oral presentations, or by a combination of these, as prescribed for each course. The dissertation will be assessed and there may be an oral examination on completion of the programme. Candidates must pass all courses at an appropriate standard for the award of the MSc degree. 2LMNg ‡ ‹ Þ ì È Ð % & ' . / ñ íÞÌÞíº¦•¦•¦•„•¦•saR@s•s#h:;¨h:;¨>*CJOJQJ^JaJh9’>*CJOJQJ^JaJ#h:;¨h9’>*CJOJQJ^JaJ h:;¨h9’CJOJQJ^JaJ h:;¨hÝd4CJOJQJ^JaJ h:;¨hxìCJOJQJ^JaJ&h:;¨hxì6CJOJQJ]^JaJ#h:;¨h9’5CJOJQJ^JaJ#h:;¨hxì5CJOJQJ^JaJh:;¨5CJOJQJ^JaJ#h:;¨h:;¨5CJOJQJ^JaJ2MN † ‡ Ç È ÆÇ & ' [ Ž ñ ;<`òåòòòòòòòòÓÓòòòòòòòòÂò$„Ðdð¤^„Ða$gd:;¨$ Æ0dð¤a$gd:;¨$dð¤a$gd:;¨$dð¤a$gd:;¨ñ ;hiÇÍÎæéò¦§ÉËÌÍÓòö ïÞÍÞ¼ÍÞ¼Þ«Þ«™ŠxÞÍÞjÞÍYÞHÞ h:;¨h\CJOJQJ^JaJ h:;¨hCmCJOJQJ^JaJhÈBCJOJQJ^JaJ#h:;¨h:;¨>*CJOJQJ^JaJh9’>*CJOJQJ^JaJ#h:;¨h9’>*CJOJQJ^JaJ h:;¨hÝd4CJOJQJ^JaJ h:;¨hlÂCJOJQJ^JaJ h:;¨hxìCJOJQJ^JaJ h:;¨h9’CJOJQJ^JaJ h:;¨hnCJOJQJ^JaJ`a¡ÇòwŸÅñòD|ìíõöòòòòòòòòòòòòáòòòòÌòòòòò$„Ð„Ðdð¤^„Ð`„Ða$gd:;¨$„ dð¤^„ a$gd:;¨$dð¤a$gd:;¨ %&lm{|¬ìíôõöüïÞÍÞÍÞ¼ª˜‡ÞufTCÞCÞïÞ h:;¨hO`CJOJQJ^JaJ#h:;¨h:;¨>*CJOJQJ^JaJh9’>*CJOJQJ^JaJ#h:;¨h9’>*CJOJQJ^JaJ h:;¨hß!‡CJOJQJ^JaJ#h:;¨h\5CJOJQJ^JaJ#h:;¨h›'¤5CJOJQJ^JaJ h:;¨h\CJOJQJ^JaJ h:;¨hxìCJOJQJ^JaJ h:;¨h9’CJOJQJ^JaJ h:;¨h›'¤CJOJQJ^JaJ*åð,KLíÛÊ¹Ê¥Ê¹ÊÛ&h:;¨hxì6CJOJQJ]^JaJ h:;¨hÝd4CJOJQJ^JaJ h:;¨hxìCJOJQJ^JaJ#h:;¨hxì5CJOJQJ^JaJ#h:;¨h·55CJOJQJ^JaJ äåKLòáááÔ$d¤a$gd:;¨$ Æ„d¤a$gd:;¨$dð¤a$gd:;¨21h:p·5°‚. °ÆA!° "° # $ %°°Ä°ÄÄj˜žžžžžžž666666666vvvvvvvvv666666>666666666666666666666666666¨6666666666¸666666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€ÀÐàð2(Øè 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€ÀÐàð 0@P`p€8XøV~ OJPJQJ_HmH nH sH tH J`ñÿJ9’Normald¤ÈCJ_HaJmH sH tH ^^xì Heading 2$dð¤@&a$>*CJOJPJQJ^JaJDA òÿ¡D Default Paragraph FontRióÿ³R0Table Normalö4Ö l4Öaö(k ôÿÁ( 0No List@³ò@9’ List Paragraph ^„Ðm$R™R \0Balloon Textdð¤CJOJQJ^JaJNþ¢N\0Balloon Text CharCJOJQJ^JaJPþ¢!PxìHeading 2 Char>*CJOJPJQJ^JaJPK!‚Š¼ú[Content_Types].xml¬‘ËjÃ0E÷…þƒÐ¶Ørº(¥ØÎ¢Iw},Òä±-j„4 Éßwì¸Pº-t#bÎ™{U®ã “óTéU^h…d}ã¨«ôûî)»×*1Pƒ'¬ô “^××Wåî0)™¦Též9<“l#¤Ü$yi}å;À~@‡æ¶(îŒõÄHœñÄÐuù*D× zƒÈ/0ŠÇ° ðûù$€˜X«Ç3aZ¢ÒÂà,°D0j~è3ß¶Îbãí~i>ƒØÍ3¿\`õ?ê/ç[Ø¬¶Géâ\Ä!ý-ÛRk.“sþÔ»..—·´aæ¿?ÿÿPK!¥Ö§çÀ6_rels/.rels„ÏjÃ0‡ï…½ƒÑ}QÒÃ%v/¥C/£}á(h"ÛëÛOÇ »„¤ï÷©=þ®‹ùá”ç šªÃâC?Ëháv=¿‚É…¤§%[xp†£{Ûµ_¼PÑ£<Í1¥H¶0•ˆÙO¼R®BdÑÉÒJEÛ4b$§‘q_×˜žà6LÓõR×7`®¨Éÿ³Ã0ÌžOÁ¯,åEn7”Liäb¡¨/ãS½¨eªÔÐµ¸ùÖýÿÿPK!ky–ƒŠtheme/theme/themeManager.xmlÌM Ã @á}¡wÙ7c»(Eb²Ë®»öCœAÇ ÒŸÛ×åãƒ7ÎßÕ›K Y,œ ŠeÍ.ˆ·ð|,§¨ÚHÅ,láÇæéxÉ´ßIÈsQ}#Õ…µÝ Öµ+Õ!ï,Ý^¹$j=‹GWèÓ÷)âEë+& 8ýÿÿPK!–µâ–Ptheme/theme/theme1.xmlìYOoÛ6¿Øw toc'vuŠØ±›-MÄn‡i‰–ØP¢@ÒI}Úã€Ãºa‡Øm‡a[Ø¥û4Ù:lÐ¯°GR’ÅX^’6ØŠ>$ùãûÿ©«×îÇ!)OÚ^ýrÍC$ñy@“°íÝö/yH*œ˜ñ„´½)‘Þµ÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ©OÐP“ô6râ=¯‰’zÀgb Ig…ÁuSÙebÖö€OÀ†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0÷+[}`j×ëõº½zAÏ°ïƒ¦V–2ÍFÞÉi–@öqžv·Ö¬5\|‰þÊœÌN§Óle²X¢dsøµÚjcsÙÁÅ7çðÎf·»êà ÈâWçðý+Õ†‹7 ˆÑä`ÚïgÔÈ˜³íJøÀ×j|†‚h(¢K³óD-Šµßã¢ dXÑ©iJÆØ‡(îâx$(Öð:Á¥;äË¹!ÍI_ÐTµ½S1£÷êù÷¯ž?EÇž?øéøáÃã?ZBÎªmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&Î‹/ŸüöìÉ‹¯>ýý»GðMGeøÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:Äµàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€ íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i~™Véþvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘â˜• ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*Ý¾Ë¦±‹ŠTÑ¼9/#·øA7ÂqZ…Ð$*c?¢íqUßån†èwðNºû%Ž»O¯·ièˆ4=3Ú—Pª ÓäïÊ1£Pm\\9†øâëÇ‘õ¶âMØ“ª2aûDù]„;Yt»\ôí¯¹[x’ìóùç]É}Wr½ÿ|É]”Ïg-´³Ú eW÷ ¶)6-r¼°CSÆjÊÈ išd ûDÐ‡A½ÎœIqbJ#xÌêºƒ6kàê#ª¢A„Sh°ëž&ÊŒt(QÊ%ìÌp%m‡&]ÙcaSl=XíòÀ¯èáü\P1»MhŸ9£Mà¬ÌV®dDAí×aV×B™[ÝˆfJÃP|8¯Ö„AÛV^…ó¹f ÌH ín÷ÞÜ-Æé"á€d>ÒzÏû¨nœ”ÇŠ¹ €Ø©ð‘>äbµ·–&ûÜÎâ¤2»Æv¹÷ÞÄKyÏ¼¤óöD:²¤œœ,AGm¯Õ\nzÈÇiÛÃ™ã¼.uÏ‡YC¾6ìOMf“å3o¶rÅÜ$¨Ã5…µûœÂNH…T[XF64ÌT,Ñœ¬üËM0ëE)`#ý5¤XYƒ`ø×¤;º®%ã1ñUÙÙ¥m;ûš•R>QD¢àØDìcp¿UÐ' ®&LEÐ/p¦m¦Üâœ%]ùöÊàì8fi„³r«S4Ïd7y\È`ÞJân•²åÎ¯ŠIùR¥Æÿ3Uô~7+ö€×¸#¯mq¨BiDý¾€ÆÁÔˆ¸‹…i*¸L6ÿ9ÔÿmÎY&áÀ§öiˆ…ýHE‚=(K&úN!VÏö.K’e„LD•Ä•©{D ê¸ª÷vEê¦šdeÀàNÆŸûžeÐ(ÔMN9ßœRì½6þéÎÇ&3(åÖaÓÐäö/D¬ØUíz³<ß{ËŠè‰Y›ÕÈ³˜•¶‚V–ö¯)Â9·Z[±æ4^næÂç5†Á¢!Já¾é?°ÿQá3ûeBo¨C¾µÁ‡MÂ¢ú’m<.vp“´Á¤IYÓf“¶Z¾Y_p§[ð=al-ÙYü}NcÍ™ËÎÉÅ‹4vfaÇÖvl¡©Á³'S†ÆùAÆ8Æ|Ò*uâ£{àè-¸ßŸ0%M0Á7%¡õ˜<€ä·ÍÒ¿ÿÿPK! ÑŸ¶'theme/theme/_rels/themeManager.xml.rels„M Â0„÷‚wooÓº‘&ÝˆÐÔ„ä5 6?$Qìí ®,.‡a¾™i»—Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!‚Š¼ú[Content_Types].xmlPK-!¥Ö§çÀ6+_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!–µâ–PÑtheme/theme/theme1.xmlPK-! ÑŸ¶'› theme/theme/_rels/themeManager.xml.relsPK]– L $ÿÿÿÿñ L `LðLð#ð†AÅA@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðSð¿Ëÿ ?ð$)*0N N33 !!1LMM%&ÇÇÍÍææøøÉËôõKNãL>ºÚäÿÿÿÿÿÿÿÿÿIk²;ÆVš)ÿÿÿÿÿÿÿÿÿ5G¤B+ìÿÿÿÿÿÿÿÿÿ0¬j” šÿÿÿÿÿÿÿÿÿõsÃ}À‹ ›ÿÿÿÿÿÿÿÿÿ„Ð„˜þÆÐ^„Ð`„˜þOJQJ^Jo(" „ „˜þÆ ^„ `„˜þOJQJ^Jo( „p„˜þÆp^„p`„˜þ.„@„˜þÆ@^„@`„˜þ.„„˜þÆ^„`„˜þ.„à„˜þÆà^„à`„˜þ.„°„˜þÆ°^„°`„˜þ.„€„˜þÆ€^„€`„˜þ.„P„˜þÆP^„P`„˜þ.„ „˜þ^„ `„˜þOJQJo(·ð€„p„˜þ^„p`„˜þOJQJ^Jo(o€„@„˜þ^„@`„˜þOJQJo(§ð€„„˜þ^„`„˜þOJQJo(·ð€„à„˜þ^„à`„˜þOJQJ^Jo(o€„°„˜þ^„°`„˜þOJQJo(§ð€„€„˜þ^„€`„˜þOJQJo(·ð€„P„˜þ^„P`„˜þOJQJ^Jo(o€„ „˜þ^„ `„˜þOJQJo(§ð„Ð„˜þÆÐ^„Ð`„˜þOJQJ^Jo(" #„ „˜þÆ ^„ `„˜þOJQJ^Jo( „p„˜þÆp^„p`„˜þ.„@„˜þÆ@^„@`„˜þ.„„˜þÆ^„`„˜þ.„à„˜þÆà^„à`„˜þ.„°„˜þÆ°^„°`„˜þ.„€„˜þÆ€^„€`„˜þ.„P„˜þÆP^„P`„˜þ.„Ð„˜þ^„Ð`„˜þCJOJQJaJo(·ð€„ „˜þ^„ `„˜þOJQJ^Jo(o€„p„˜þ^„p`„˜þOJQJo(§ð€„@„˜þ^„@`„˜þOJQJo(·ð€„„˜þ^„`„˜þOJQJ^Jo(o€„à„˜þ^„à`„˜þOJQJo(§ð€„°„˜þ^„°`„˜þOJQJo(·ð€„€„˜þ^„€`„˜þOJQJ^Jo(o€„P„˜þ^„P`„˜þOJQJo(§ð„Ð„˜þ^„Ð`„˜þOJQJo(·ð€„ „˜þ^„ `„˜þOJQJ^Jo(o€„p„˜þ^„p`„˜þOJQJo(§ð€„@„˜þ^„@`„˜þOJQJo(·ð€„„˜þ^„`„˜þOJQJ^Jo(o€„à„˜þ^„à`„˜þOJQJo(§ð€„°„˜þ^„°`„˜þOJQJo(·ð€„€„˜þ^„€`„˜þOJQJ^Jo(o€„P„˜þ^„P`„˜þOJQJo(§ðãL>àqó 5G¤Bðpó Ik²;0¬jõsÃ}ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿbvtÂÜ‰x:á–,~VP$ÖÛP…$c@%âýZärfM<¹— (N2HndµJ`TôÖÊúÚœ\þ¶à`n,þœ/ò¼.¬Î¤ÔV /Y_ å ÈBO`/) v3Ýd4·5<;ôCJ²(P+X\MaÓrcCmn³Bwß!‡9’›'¤:;¨u)³å)³°QµlÂÓQÉësÖ!\Ú«Ûópèxì cþLNÿ@Lh@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿ G‡* €ÿTimes New Roman5€Symbol3.‡* €ÿArial7.ï { @ŸCalibriY CG TimesTimes New Roman5.‡*a€ÿTahoma?= ‡* €ÿCourier New;€WingdingsAï ë BŸCambria Math"qˆðÐh…ó'iŠ§ó'Õw Õw !ð ´´20FF3ƒðüýHX ðÿ $Päÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ9’2!xx ÿÿMelanie McCannadr152 þÿà…ŸòùOh«‘+'³Ù0t˜¤°ÈÔè ø $0< HT\dläMelanie McCannNormal.dotmadr1524Microsoft Office Word@ @Ná]SnÍ@fîìSnÍ@¶ýT|ÍÕw þÿÕÍÕœ.“—+,ù®DÕÍÕœ.“—+,ù®@ühp˜ ¨°¸ÀÈ ÐÝäºÚÁÏÍøFTitleD@ÃË×ß'_NewReviewCycle_AdHocReviewCycleID_EmailSubject _AuthorEmail_AuthorEmailDisplayNameäÕ"ª SENAS: New programme proposalr.j.findlay@abdn.ac.ukFindlay, Robert J þÿÿÿ !"#$%&'(þÿÿÿ*+,-./0þÿÿÿ2345678þÿÿÿýÿÿÿ;þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀFàÿƒ$T|Í=€1Tableÿÿÿÿÿÿÿÿ*WordDocumentÿÿÿÿÿÿÿÿ4$SummaryInformation(ÿÿÿÿ)DocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ1CompObjÿÿÿÿÿÿÿÿÿÿÿÿyÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.8ô9²q